Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05378100

Organisation Name: Johns Hopkins University

Overal Status: Not yet recruiting

Start Date: December 1, 2022

Last Update: September 9, 2022

Lead Sponsor: Johns Hopkins University

Brief Summary: The proposed study is a single-center, phase II, randomized, double-blind, parallel-group, active-placebo-controlled trial of intravenous low-dose ketamine in patients with MS fatigue.

Conditions:
  • Multiple Sclerosis Fatigue


Total execution time in seconds: 0.6205780506134